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Abstract
Purpose: This paper presents initial experimental results from a prototype of HDR BrachyView,20
a novel in-body source tracking system for HDR brachytherapy based on a multi-pinhole tungsten
collimator and a high resolution pixellated silicon detector array. The probe and its associated
position estimation algorithms are validated and a comprehensive evaluation of the accuracy of its
position estimation capabilities is presented.
Method: The HDR brachytherapy source is moved through a sequence of positions in a prostate25
phantom, for various displacements in x, y and z. For each position, multiple image acquisitions are
performed, and source positions are reconstructed. Error estimates in each dimension are calculated
at each source position and combined to calculate overall positioning errors. Gafchromic film is
used to validate the accuracy of source placement within the phantom.
Results: More than 90% of evaluated source positions were estimated with an error of less30
than one millimetre, with the worst-case error being 1.3 mm. Experimental results were in close
agreement with previously published Monte Carlo simulation results.
Conclusion: The prototype of HDR BrachyView demonstrates a satisfactory level of accuracy in
its source position estimation, and additional improvements are achievable with further refinement
of HDR BrachyView’s image processing algorithms.35
PACS numbers: 87.53.Jw,87.55.N-,87.55.Qr,87.56.Fc,87.57.nj,87.57.uq
Keywords: in vivo dosimetry, brachytherapy, HDR, BrachyView
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I. INTRODUCTION
High dose rate brachytherapy is currently one of the leading treatment options for clini-
cally localised prostate cancer1–3. While an excellent dose distribution is achieved within the40
target volume, the surrounding tissue is spared due to the rapid reduction in dose rate with
distance2,4. Additionally, the use of afterloaders in placing and moving the source avoids
radiation exposure to the operators5. Accurate source placement within the prostate volume
for the pre-calculated dwell times is a crucial factor in the success of the treatment, and
minimises the occurrence and severity of radiation toxicity within nearby organs such as the45
rectum, urethra and bladder6. Therefore, accurate real-time monitoring of source position
will be a valuable addition to existing quality assurance (QA) methods for high dose rate
prostate brachytherapy (HDR-PBT)7,8.
Many approaches have been proposed for HDR PBT source positioning QA. Recent trends
in this field have concentrated on real-time position or dosimetry measurement, such that the50
effect of geometrical changes in the prostate and surrounding organs between the treatment
plan and the source delivery can be compensated for in real-time. Passive dosimetry methods
such as TLDs cannot provide real-time dosimetry or position feedback; therefore, active
methods based on electronic radiation detectors are more feasible for real-time QA in HDR
PBT.55
A variety of applications of metal oxide semiconductor field effect transistor (MOSFET)
detectors in HDR PBT dosimetric QA have been investigated9,10. The MOSkin probe is
a novel type of ultra-thin MOSFET-based dosimeter developed by the Centre for Medical
Radiation Physics (CMRP) at the University of Wollongong. Its extremely thin sensitive
volume provides a water-equivalent depth of approximately 0.07 mm, which makes MOSkin60
an optimal dosimeter for the measurement of radiation fields with steep dose rate gradients
on the surface of critical organs11–13. Recently, Tenconi et al. proposed a method for inte-
grating the MOSkin dosimeter with a trans-rectal ultrasound (TRUS) probe to provide in
vivo measurements of the dose received by the rectal wall in real time at predefined and
anatomically relevant points. This study reported an average difference of -0.6 ± 2.6% be-65
tween the delivered dose and the desired dose calculated by the treatment planning system
(TPS)14. Carrara et al. have successfully tested this QA method on six patients undergoing
HDR PBT and used it to quantify intra-fraction prostate motion15.
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An alternative real-time dose monitoring method for HDR PBT uses dosimeters based
on an Al2O3:C crystal coupled by optical fibre to a photomultiplier or solid state photon70
detector16–18. Such detectors can measure dose both via radioluminescence (yielding an
instantaneous dose measurement) or through optically stimulated luminescence (integrated
over the exposure time since the last optical readout pulse). The former mode of operation
is most appropriate for real-time dosimetric QA in HDR PBT. Cartwright et al. performed
in-rectum dosimetry using 16 fibre-coupled scintillators placed in a trans-rectal applicator,75
and obtained measurements within 3% of the intended dose as calculated by the TPS. This
method is able to provide an estimate of source position in one dimension with an accuracy of
approximately 2 mm19. Although fibre-coupled scintillator dosimetry can accurately monitor
the dose rate at selected sampling positions in real-time, it provides insufficient information
to be able to determine the position of the source, and the spatial distribution of dose cannot80
be accurately estimated.
Wang et al. proposed a method to validate the source delivery accuracy of the afterloader
in one dimension in real-time. Two GaN dosimetric probes were used to track the horizontal
displacement of the source within a predefined catheter location. Although sub-millimetre
accuracy is achieved, this method is very limited in application since source position infor-85
mation is only available in one dimension (parallel to the catheter) and the position of the
catheter relative to the probes has to be known in advance and assumed to be correct20. A
more sophisticated QA system, capable of providing detailed pretreatment QA information
including source position in the phantom volume with sub-millimetre accuracy and source
dwell and transit time was proposed and investigated by Espinoza et al.21. Using the Magic90
Phantom, a phantom with two rows of ten uniformly spaced catheters with the Magic Plate
silicon diode array placed in-between to track the source position, dwell time as well as the
two dimensional dose distribution were determined21,22.
Methods using an external imaging device combined with a pinhole or analogous col-
limator have been proposed and aim to provide intra-fraction real-time source tracking.95
However, due to the large source to collimator distance, these methods either require a
lengthy acquisition time (more than 2 s for a HDR source of typical activity), which is too
slow for real-time source tracking, or suffer from an unacceptable positioning error (larger
than 3 mm, suggested by Tiong et al.23)24–26.
BrachyView is a family of in-body imaging systems developed at the University of Wol-100
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longong’s Centre for Medical Radiation Physics (CMRP), which combine a multi-pinhole
tungsten collimator with an array of Timepix detectors27. BrachyView aims to provide re-
liable intra-fraction realtime source tracking. The application of BrachyView in low dose
rate (LDR) PBT (LDR BrachyView) has been investigated using 125I seeds and a PMMA
phantom. Sub-millimetre accuracy can be obtained within an acquisition time of 3 s when105
seeds are placed within 20 mm of the collimator’s upper surface; this error increases with
source-to-detector distance and reaches 3 mm when the seeds are 60 mm away28. The capa-
bility of BrachyView (with the collimator removed) to additionally perform X-ray imaging
of soft tissue in PBT has also been evaluated29. The related HDR BrachyView device, in-
tended for QA of high dose rate (HDR) PBT, has previously been characterised in detail110
via Monte Carlo simulations, which predicted that a maximum error of 1.5 mm within the
maximum extent of the prostate volume could be obtained within a sub-second acquisition
time (with the source up to 45 mm away from the collimator’s top surface)30. Furthermore,
additional Monte Carlo simulations and preliminary experimental work have demonstrated
that the dose enhancement at the rectal wall resulting from backscatter from the HDR115
BrachyView probe’s tungsten shell is negligible provided that the probe is encapsulated in
a tissue-equivalent plastic shell with a thickness of at least 0.5 mm31.
The aim of this paper is to experimentally evaluate the efficiency and accuracy of source
position tracking using the HDR BrachyView probe. The estimated source position will
ultimately be registered to the prostate by combining HDR BrachyView with a transrectal120
ultrasound (TRUS) probe30.
The remainder of this paper is arranged as follows: the experimental configuration and
the source position reconstruction algorithm are discussed in Section II; the source position
estimates are calculated and compared with planned positions in Section III; a thorough
analysis of the results including a discussion of the possible sources of error is presented in125
Section IV; and finally, conclusions and possible approaches to improve accuracy are given
in Section V.
II. MATERIAL AND METHODS
A prototype HDR BrachyView probe has been developed at the Centre for Medical Ra-










FIG. 1. The prototype HDR BrachyViewprobe (actual and schematic with coordinate system),
together with its linear translational stage and the phantom.
sub-second dwell times was evaluated experimentally. The design of the prototype and the
experimental configuration is described in Section IIA. A comprehensive description of the
source tracking process is provided in Section II B.
A. Experimental configuration
The experiment was conducted at the HDR Brachytherapy facilities at the St. George135
Hospital Cancer Care Centre, Kogarah. The configuration consists of four main components:
the HDR BrachyView prototype probe, a linear translational stage, a simplified prostate
phantom, and a HDR brachytherapy source and afterloader mechanism.
The experimental configuration is shown in FIG. 1(a) and a schematic of the probe and
the Solid water phantom is illustrated in FIG. 1(b).140
The prototype probe consists of a semi cylindrical tungsten collimator, coupled to a semi-
cylindrical aluminium base of the same diameter which houses two tiled Timepix detector
arrays. The two 14 mm × 14 mm Timepix detectors provide a 14 mm × 28 mm sensitive
detection area27. Together with their associated microprocessor-controlled USB2 interfaced
readout system (Fitpix) they give the probe the capability of imaging the source within half145
of the target volume (FIG. 2(a)), i.e. the prostate phantom, at a frame rate of up to 400
images per second and with very low electronic noise. A global cartesian coordinate system
was introduced and is shown in FIG. 1(b), with its origin placed at the top left corner of
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(a)Longitudinal cross-section (b)Transversal cross-section
FIG. 2. The cross-sections of the HDR BrachyView prototype probe, the phantom and the planned
source positions. The catheter positions used in the experiment are marked within the phantom.
the first detector (first row and first column of the imaging plane).
Seven double cone equidistant pinholes (centre-to-centre spacing of 6.5± 0.05 mm) were150
drilled onto the collimator, parallel to the central axis of the detectors (along the y axis)
and are shown in FIG. 2(a). The acceptance angle of the double cone pinhole is 90◦ ± 0.5◦.
A cylindrical channel with a diameter of 0.5 mm and a length of 0.5 mm connects the top
and bottom cones.
The geometry of the truncated double cone pinholes and their preferred placement have155
been discussed in previous publications30,31. However, the geometry of the prototype board
on which the Timepix chips were mounted was such that it was not possible to align the
centre of the detectors with the centre of the collimator tube. Therefore the pinholes were
fabricated with the same offset as the detectors, as illustrated in FIG. 2(b).
It was demonstrated previously that four tiled detectors are needed to cover the whole160
prostate volume30. However, the axial symmetry of the phantom allows for the evaluation
of the probe performance by moving the source within half of the field of view (FOV).
The phantom comprises a series of 90 mm×90 mm Computerized Imaging Reference Sys-
tems (CIRS) Plastic Water R© LR sheets, each with a thickness of either 5 mm or 10 mm and
optimised for photon energies from 15 keV to 8 MeV. A 2 mm diameter channel was etched165
halfway along the central axis (y axis) of a 90 mm×90 mm×10 mm Plastic Water sheet.
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TABLE I. Planned Source Positions for each test.
Test
Source Positions
x (mm) y(mm) z (mm)
1 7.0
5 positions from
13.5 to 29.5 with









This allowed for the insertion of a catheter into which a Flexitron 192Ir HDR brachyther-
apy source was remotely moved by a Nucletron Flexitron HDR afterloader. The source
was moved into five preplanned positions along the y axis, starting at the entrance of the
catheter within the phantom and moving in the positive y direction in steps of 4 mm.170
The Plastic Water sheets were arranged to place the catheter either 40 mm or 60 mm
above the detector plane of the HDR BrachyView probe along the y axis, as illustrated in
FIG. 1(b) and FIG. 2. The upper catheter position is set at 60 mm, since in clinical practice,
60 mm is generally considered the upper limit of the possible distance between rectal wall
and the most distant needle placed inside the prostate for treatment.175
A linear translational stage with a 1 µm accuracy was used to move the probe laterally
(along the x axis) in four 2.5 mm steps, relative to the phantom and the catheter (FIG.
2(b)). A total of eight catheter positions were thus simulated. The position of the phantom
relative to the probe is shown in FIG. 2(a), where the front face of the phantom is offset
from the centre of the first pinhole by 0.3 mm, due to the mechanical constraints of the180
experimental apparatus.
The source air kerma strength at the time of irradiation was 19.5 mGyh−1m2, correspond-
ing to approximately 50% of the full source strength of 40.7 mGyh−1m2. Source dwell times
in each position were calculated as 43 s, equivalent to 20.6 s for a full strength source. A
list of all planned source positions is provided in Table I.185
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FIG. 3. The process of calculating the source position within the prostate volume.
B. Reconstruction method
The two Timepix chips are calibrated and equalised to ensure a uniform response across
the full array and configured to continuously acquire and record frames with an exposure
time of 0.1 second (with a short dead time between each frame acquisition). Groups of
ten consecutive frames are combined to produce images with an effective exposure time of190
one second; an average of 18 such images are collected for each source position, with any
frames captured during source movement discarded. The images collected for each source
position are then passed through a 3×3 median filter, after which the small gap between
the chips is filled via bilinear interpolation. The projections are separated via a simple
image segmentation process and then thresholded. The centres of mass (CoMs) of all visible195
projections, which are used as an approximation for the projected source centre, can then
be computed. The CoMs are then backprojected through their corresponding pinholes and
the three dimensional source location, defined as the point with the minimum mean square
distance to all of these rays, is found for each one-second acquisition30. A unique source
location can be found even if the source is not visible through all pinholes; all potential200
candidate source positions are calculated, and the point with the shortest distance to the
CoM of the brightest projection is taken as the true source position30. The procedure is
repeated for all 18 images collected at each source position, and the mean and standard
deviation of the source position estimate are calculated across the image set for each source
position.205
A block diagram of the steps involved in the calculation of source location is shown in
FIG. 3.
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At every position, the source is seen by multiple pinholes, with varying source to pinhole
distance. The photon flux is, to the first approximation, inversely proportional to the square
of the distance and therefore the signal to noise (SNR) decreases with an increase in the210
source to pinhole distance. To overcome this problem, a dual thresholding scheme was
implemented, whereby a global threshold was applied to the original image and the CoMs of
all projections were roughly estimated. Using these CoMs as a guide, the original image was
segmented and individually thresholded locally, as a constant fraction of the peak intensity
of the CoM, for a more accurate estimation of its coordinate on the detector plane.215
The pixels at the boundary between the two adjacent detectors were observed to suffer
from very high levels of background noise. The counts recorded by these pixels are replaced
by a bilinear interpolation between the neighbouring pixel values. An example of the detector
response recorded before and after the correction is shown in (FIG. 4).
C. Verification of displacement along the y axis220
The source displacement along the y axis was independently verified using a set of film pro-
jection images, taken concurrently with the measurements acquired by the HDR BrachyView
probe.
Gafchromic R© EBT3 films were cut into 90 mm × 90 mm pieces and inserted between
the plastic water sheets comprising the phantom, 5 mm below the centre of the catheter.225
The source was moved into a series of three pre-planned positions along the y axis in steps
of 10 mm, starting at the entrance of the catheter within the phantom. The measurements
were repeated for two source to detector plane distances of 40 mm and 60 mm.
The source projection images on each film were analysed and their CoMs were calculated.
The positions of the CoMs along the y-axis were then compared with the source positions230
tracked by the HDR BrachyView probe.
III. RESULTS
The mean estimated source positions are plotted in FIG. 5, both in three dimensions and
projected on to the three main planes of the coordinate system (defined in Section IIA);
























(c)Line profile, before interpolation

















(d)Line profile, after interpolation
FIG. 4. Source projection shown at the boundary of the two Timepix detectors; the non-uniform
response of the detector array has been corrected using bilinear interpolation.
The same data together with the standard deviation of the calculated source positions,
mean error in each dimension (difference between planned and estimated positions), stan-
dard deviation of the mean errors in each dimension for each different catheter (intra-run
standard deviation), overall standard deviation of the mean errors in each dimension (inter-
run standard deviation) and overall mean error are shown in Tables II and III for nominal240
vertical (z) source-detector distances of 40 mm and 60 mm respectively. Larger errors (nom-
inal to measured) and uncertainties (standard deviation between measurements) were found
for the larger vertical source-detector distance, especially in the z direction. For 60 mm
nominal vertical source-detector distance, the maximum overall error is 1.3 mm, whereas for
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(a)Three-dimensional view (b)Projection on x− y plane
(c)Projection on x− z plane (d)Projection on y − z plane
FIG. 5. Coordinates of calculated and planned source positions, visualised in three dimensions and
projected on to the three main planes of the coordinate system.
40 mm, the maximum overall error is 1 mm. The largest contribution to the overall error245
in the position estimate for each catheter position (i.e., the intra-run standard deviations)
is from the z component. For both source-detector distances, the uncertainties in the y-
component of the error are always smaller than the overall error values (inter-run standard
deviations), while the x component of the position estimate exhibits the smallest intra- and
inter-run standard deviations of the three components.250
FIG. 6 shows the image recorded on EBT3 Gafchromic film (placed 5 mm below the
source) when the source is located 60 mm above the top of the detector (the image obtained
when the source is located at z = 40 mm is essentially identical as the source-film distance
12
TABLE II. The coordinates of calculated and planned source positions for a vertical source dis-
placement of 40 mm from the top surface of the detector plane. Standard deviation is denoted
SD; intra-run means and standard deviations are calculated across 18 one-second (10 × 0.1 s)










Mean Estimated Source Positions




x y x SDx y SDy z SDz dx dy dz dtotal
7.0 13.5 7.1 0.02 13.5 0.09 40.6 0.14 0.1 0.0 0.6 0.6
7.0 17.5 7.1 0.03 17.5 0.09 40.8 0.20 0.1 0.0 0.8 0.8
7.0 21.5 7.2 0.03 21.2 0.14 40.5 0.20 0.2 -0.3 0.5 0.6
7.0 25.5 7.1 0.03 25.6 0.07 40.4 0.16 0.1 0.1 0.4 0.4
1
7.0 29.5 7.1 0.02 29.1 0.12 39.9 0.19 0.1 -0.4 -0.1 0.4
9.5 13.5 9.8 0.04 14.0 0.23 40.8 0.30 0.3 0.5 0.8 1.0
9.5 17.5 9.8 0.05 18.1 0.04 40.8 0.22 0.3 0.6 0.8 1.0
9.5 21.5 9.7 0.03 21.7 0.05 40.2 0.16 0.2 0.2 0.2 0.3
9.5 25.5 9.7 0.03 26.0 0.11 40.1 0.15 0.2 0.5 0.1 0.5
4
9.5 29.5 9.8 0.03 29.8 0.09 40.1 0.16 0.3 0.3 0.1 0.4
12.0 13.5 12.2 0.04 13.9 0.03 40.0 0.14 0.2 0.4 0.0 0.4
12.0 17.5 12.3 0.04 18.0 0.06 40.2 0.13 0.3 0.5 0.2 0.6
12.0 21.5 12.1 0.04 21.5 0.08 39.7 0.17 0.1 0.0 -0.3 0.3
12.0 25.5 12.1 0.04 25.9 0.07 39.6 0.14 0.1 0.4 -0.4 0.6
5
12.0 29.5 12.2 0.02 29.8 0.06 39.7 0.11 0.2 0.3 -0.3 0.5
14.5 13.5 14.8 0.05 13.8 0.04 40.6 0.17 0.3 0.3 0.6 0.7
14.5 17.5 14.8 0.07 17.8 0.03 40.8 0.20 0.3 0.3 0.8 0.9
14.5 21.5 14.7 0.06 21.4 0.11 40.6 0.23 0.2 -0.1 0.6 0.6
14.5 25.5 14.7 0.05 25.9 0.07 40.2 0.15 0.2 0.4 0.2 0.5
8
14.5 29.5 14.7 0.05 29.7 0.09 40.1 0.14 0.2 0.2 0.1 0.3
is also 5 mm). Three horizontal source displacements were evaluated using this method
for each value of z and were used for comparison with the corresponding source positions255
tracked by the HDR BrachyView probe. Table IV shows the three source positions in the y
direction as measured by film and the HDR BrachyView probe, for both values of z. The
differences between the two methods are up to 0.31 mm for all measured source positions.
IV. DISCUSSION
The measurement of the source position when the source was placed at a nominal height260
of 60 mm above the detector plane demonstrates the performance of the HDR BrachyView
probe in terms of source tracking accuracy and consistency in the worst case for both sensitiv-
ity and minification (demagnification). Standard deviations of less than 1 mm were obtained
for all evaluated source positions within a 1 s acquisition time using a 19.5 mGyh−1m2 source
(equivalent to an acquisition time of 0.5 s for a full strength source). The increase in stan-265
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TABLE III. The coordinates of calculated and planned source positions for a vertical source dis-
placement of 60 mm from the top surface of the detector plane. Standard deviation is denoted
SD; intra-run means and standard deviations are calculated across 18 one-second (10 × 0.1 s)










Mean Estimated Source Positions




x y x SDx y SDy z SDz dx dy dz dtotal
7.0 13.5 6.9 0.09 13.1 0.07 59.4 0.63 -0.1 -0.4 -0.6 0.7
7.0 17.5 6.8 0.09 17.1 0.12 60.9 0.69 -0.2 -0.4 0.9 1.0
7.0 21.5 6.8 0.07 20.7 0.08 60.8 0.63 -0.2 -0.8 0.8 1.1
7.0 25.5 6.8 0.06 25.1 0.20 60.4 0.66 -0.2 -0.4 0.4 0.6
2
7.0 29.5 6.8 0.06 28.9 0.17 60.1 0.59 -0.2 -0.6 0.1 0.6
9.5 13.5 9.8 0.08 14.0 0.16 60.0 0.77 0.3 0.5 0.0 0.6
9.5 17.5 9.8 0.10 17.9 0.25 60.8 0.75 0.3 0.4 0.8 0.9
9.5 21.5 9.8 0.07 21.4 0.09 60.8 0.60 0.3 -0.1 0.8 0.9
9.5 25.5 9.8 0.10 25.3 0.23 60.3 0.74 0.3 -0.2 0.3 0.5
3
9.5 29.5 9.8 0.07 28.8 0.16 59.7 0.60 0.3 -0.7 -0.3 0.8
12.0 13.5 12.0 0.11 14.4 0.09 60.3 0.60 0.0 0.9 0.3 0.9
12.0 17.5 12.0 0.11 18.3 0.13 60.8 0.71 0.0 0.8 0.8 1.1
12.0 21.5 11.9 0.09 22.0 0.18 60.4 0.68 -0.1 0.5 0.4 0.6
12.0 25.5 11.8 0.09 26.1 0.20 60.4 0.85 -0.2 0.6 0.4 0.7
6
12.0 29.5 11.8 0.10 29.7 0.21 60.5 0.64 -0.2 0.2 0.5 0.6
14.5 13.5 14.2 0.13 13.8 0.10 60.4 0.74 -0.3 0.3 0.4 0.6
14.5 17.5 14.3 0.17 17.7 0.09 61.3 0.79 -0.2 0.2 1.3 1.3
14.5 21.5 14.2 0.12 21.2 0.12 60.7 0.79 -0.3 -0.3 0.7 0.8
14.5 25.5 14.0 0.14 25.0 0.21 59.7 0.68 -0.5 -0.5 -0.3 0.8
7
14.5 29.5 14.1 0.13 28.9 0.21 60.6 0.64 -0.4 -0.6 0.6 0.9
dard deviation of measurements with increased source-detector distance is expected, since
increasing this distance results in a smaller number of photons being collected within the
fixed acquisition period, reducing the signal to noise ratio in the calculation of the projec-
tion’s CoM. However, in therapeutic practice, the dwell time of the source is usually much
longer than 0.5 s; therefore, this uncertainty will be reduced when the probe is put into270
clinical use. The accuracy obtained in these experiments closely matched the performance
obtained from previously published simulation studies, although the errors are somewhat
larger due to source positioning uncertainties which are not present in the simulation30.
Several factors contribute to the error in the estimated position in the z direction. Firstly,
although the phantom itself is solid, and therefore the channel in which the catheter is275
inserted is rigid, there is a small difference of 0.333 mm between the diameter of the channel
(2 mm) and the diameter of the catheter (Flexitron Lumencath 5F, 1.667 mm). Due to the
position of the afterloader relative to the phantom, a small downward force is exerted on the
external part of the catheter, which is greater at (nominal) z = 60 mm than for z = 40 mm.
14
9.71 mm 19.73 mm 29.38 mm
FIG. 6. Magnified film image obtained for three source positions at z = 60 mm, with y-axis steps
of 10 mm. The image obtained for z = 40 mm is essentially identical.
TABLE IV. Measured position of source in y direction, as measured by EBT3 film placed 5 mm from
the source and the HDR BrachyView probe. Uncertainties are ±3σ; source centre displacement
measured from edge of phantom.
Estimated source centre displacement (mm)









This force results in the catheter being deflected into an approximately parabolic shape280
inside the channel through the phantom. The central region of the catheter is deflected
upward, while the catheter is deflected downward at both the tip of the catheter and at
the point of entrance to the phantom. This partially explains the discrepancy between the
planned and measured values of z at the nominal height of z = 60 mm - rather than being
a measurement error, it is an error in the accuracy of the experimental configuration, which285
is being correctly measured by HDR BrachyView.
The remainder of the error (at both z = 60 mm and z = 40 mm) is a consequence
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FIG. 7. Illustration of the calculation of z, demonstrating the overestimation in z that results from
using centres of mass of non-uniform-intensity source projections on the imaging plane. dICoM
and dCoM refer to the distances between adjacent ‘ideal’ (i.e. the theoretical projection of the true
source centre through the pinhole onto the imaging plane) and the computed centres of mass of
the image respectively.
of the fact that the centre of mass (CoM) of the projection is not precisely collinear with
the source and pinhole, but rather is shifted slightly both in x and y in the direction of
the pinhole. The shift is due to the source being cylindrical rather than a point source,290
with photons from the more distant end of the source travelling a greater distance to the
detector plane (and arriving at a shallower angle) compared to photons emitted from the
near end. Because of the difference in path distances, the intensity (but not the geometry)
of projections of a cylindrical source with uniform activity distribution oriented parallel to
the detector plane will be non-uniform. The CoM will therefore be biased in the direction295
of maximum projection intensity (in the direction of the pinhole) and will not perfectly
coincide with the true geometric centre of the projection.
As can be seen from FIG. 7, the error resulting from the use of the projection CoM to
estimate the geometric centre of the projection causes an overestimation of the height of
the source (i.e., a positive error in z). This error is smallest for the projections nearest to300
the source in x and y, progressively increasing in the more distant projections. Currently,
all projections are equally weighted during the position reconstruction process (with the
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estimated position being calculated as the point with minimum mean squared distance from
all backprojected lines). Therefore, position estimates for those source positions from which
a larger number of distant projections are visible will be more severely degraded by this305
error than those from which only a few nearby projections can be seen. This explains
the apparently paradoxical result that source positions above the middle of the detector
array, from which multiple projections are visible, accumulate a greater positive bias in
height estimation compared to source positions near either end of the detector array, which
effectively give more weight to the projection with a smaller error between projection CoM310
and the true geometric centre of the projection. The same error was observed in the previous
Monte Carlo simulation study, confirming that it is a consequence of the simplified methods
used to estimate the geometric centre of the projection from the projection’s CoM30.
This latter source of error will be reduced in future versions of the reconstruction soft-
ware, by using a non-equal weighting of projections (preferentially weighting the brighter315
projections, which also gives greater weight to projections with higher SNR). It will also
be possible to improve the localisation of the geometric centre of the projection by de-
convolving the projection by the point spread function of the pinhole (which will reduce
blurring, although it cannot eliminate the effect of photon penetration through the collima-
tor) and iterative post-segmentation intensity correction (i.e., following initial segmentation320
and approximate determination of the CoMs and hence source position, the intensity of the
projection can be corrected for the 1/d2 reduction in intensity, after which the CoM should
be equal to the geometric centre of the projection).
It is also noted that there is some variation in y between individual runs of the ex-
periment; this is due to the afterloader’s own intrinsic positioning error of ±1 mm (95%325
confidence interval). Incremental movements in y during each individual run remain highly
consistent, but due to mechanical backlash in the afterloader’s actuator following the com-
plete retraction and reinsertion of the source, combined with up to 0.5 mm uncertainties in
the connection between transfer tube and catheters between runs, small, random inter-run
translations in y are observed. This is demonstrated by the fact that intra-run standard330
deviation of the difference between planned and measured source positions is always smaller
than the overall uncertainties of the same values (inter-run standard deviations).
The intrinsic accuracy of HDR BrachyView (i.e., independent of afterloader positioning
error) in the y direction was further evaluated using Gafchromic films. Excellent agree-
17
ment is observed from the results of film and HDR BrachyView probe. The difference in y335
displacement between the measurements by film and the HDR BrachyView probe is signifi-
cantly smaller than the error between the estimated and planned source positions. This is
further confirmation that the catheter shift and uncertainty in its connection to the transfer
tube or afterloader positioning uncertainty are the main reason for the differences between
planned and estimated source position in the y direction shown in Tables II and III.340
V. CONCLUSION
In this paper, the results of the experimental evaluation of the HDR BrachyView probe in
terms of source tracking accuracy have been presented. Most planned source positions (more
than 90%) were measured with sub-millimetre accuracy within an equivalent acquisition time
of 0.5 s for a full strength HDR source, with the largest difference found between planned and345
measured source position being 1.3 mm (although part of that error is a result of uncertainties
in the mechanical positioning of the source). The overall performance, including a systemic
overestimation of the source height, was in good agreement with the results of the previous
GEANT4 simulation study, and can potentially be improved through more sophisticated
image processing techniques. In future work, a fully-populated four-detector prototype with350
integrated transrectal ultrasound is under development, which will be able to register the
calculated source position with the prostate volume.
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